Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. [electronic resource]
Producer: 20060127Description: 665-70 p. digitalISSN:- 0735-7907
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Doxorubicin -- administration & dosage
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasms -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.